Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Evaluating the use of whole genome sequencing for the investigation of a large mumps outbreak in Ontario, Canada.

Stapleton PJ, Eshaghi A, Seo CY, Wilson S, Harris T, Deeks SL, Bolotin S, Goneau LW, Gubbay JB, Patel SN.

Sci Rep. 2019 Aug 30;9(1):12615. doi: 10.1038/s41598-019-47740-1.

2.

Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002-2016.

Buchan SA, Daneman N, Wang J, Garber G, Wormsbecker AE, Wilson SE, Deeks SL.

Clin Infect Dis. 2019 Aug 22. pii: ciz769. doi: 10.1093/cid/ciz769. [Epub ahead of print]

PMID:
31436814
3.

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.

Drolet M, Bénard É, Pérez N, Brisson M; HPV Vaccination Impact Study Group.

Lancet. 2019 Aug 10;394(10197):497-509. doi: 10.1016/S0140-6736(19)30298-3. Epub 2019 Jun 26.

PMID:
31255301
4.

Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study.

Bolotin S, Severini A, Hatchette T, McLachlan E, Savage R, Hughes SL, Wang J, Deeks SL, Wilson S, Brisson M, Halperin SA, Gubbay J, Mazzulli T, Serhir B, Ward BJ, Crowcroft N.

Hum Vaccin Immunother. 2019 Jul 16:1-9. doi: 10.1080/21645515.2019.1619402. [Epub ahead of print]

PMID:
31184979
5.

Characteristics of immunized and un-immunized students, including non-medical exemptions, in Ontario, Canada: 2016-2017 school year.

Wilson SE, Murray J, Bunko A, Johnson S, Buchan SA, Crowcroft NS, Dubey V, Loh LC, MacLeod M, Taylor C, Deeks SL.

Vaccine. 2019 May 21;37(23):3123-3132. doi: 10.1016/j.vaccine.2019.04.033. Epub 2019 Apr 24.

6.

Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015.

Ramsay LC, Crowcroft NS, Thomas S, Aruffo E, Teslya A, Heffernan JM, Gournis E, Hiebert J, Jaeger V, Jiaravuthisan M, Sharron J, Severini A, Deeks SL, Gubbay J, Mazzulli T, Sander B.

Euro Surveill. 2019 Mar;24(11). doi: 10.2807/1560-7917.ES.2019.24.11.1800370.

7.

Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.

Wilson SE, Rosella LC, Wang J, Renaud A, Le Saux N, Crowcroft NS, Desai S, Harris T, Bolotin S, Gubbay J, Deeks SL.

Vaccine. 2019 Apr 17;37(17):2408-2414. doi: 10.1016/j.vaccine.2019.01.061. Epub 2019 Feb 11.

8.

Demonstration of background rates of three conditions of interest for vaccine safety surveillance.

Wormsbecker AE, Johnson C, Bourns L, Harris T, Crowcroft NS, Deeks SL.

PLoS One. 2019 Jan 15;14(1):e0210833. doi: 10.1371/journal.pone.0210833. eCollection 2019.

9.

Limitations of administrative data to identify measles cases in Ontario, Canada: a cautionary tale.

Johnson C, Chen C, Rosella L, Rilkoff H, Marchand-Austin A, Gubbay JB, Kozlowski T, Deeks SL, Mazzulli T, Crowcroft N.

Can J Public Health. 2018 Feb;109(1):3-7. doi: 10.17269/s41997-018-0021-1. Epub 2018 Feb 26.

PMID:
29981059
10.

Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations.

Deeks SL, Tunis MC, Ismail S; National Advisory Committee on Immunization (NACI).

Can Commun Dis Rep. 2017 Jun 1;43(6):138-142. eCollection 2017 Jun 1.

11.

Under-reporting of pertussis in Ontario: A Canadian Immunization Research Network (CIRN) study using capture-recapture.

Crowcroft NS, Johnson C, Chen C, Li Y, Marchand-Austin A, Bolotin S, Schwartz K, Deeks SL, Jamieson F, Drews S, Russell ML, Svenson LW, Simmonds K, Mahmud SM, Kwong JC.

PLoS One. 2018 May 2;13(5):e0195984. doi: 10.1371/journal.pone.0195984. eCollection 2018.

12.

Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program.

Isabel S, Higgins RR, Peci A, Isabel MR, Deeks SL, Gubbay JB.

Vaccine. 2018 Apr 5;36(15):2033-2040. doi: 10.1016/j.vaccine.2018.02.064. Epub 2018 Mar 8.

PMID:
29526372
13.

Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.

Wilson SE, Chung H, Schwartz KL, Guttmann A, Deeks SL, Kwong JC, Crowcroft NS, Wing L, Tu K.

PLoS One. 2018 Feb 14;13(2):e0192809. doi: 10.1371/journal.pone.0192809. eCollection 2018.

14.

T-cell receptor excision circle levels and safety of paediatric immunization: A population-based self-controlled case series analysis.

Wilson K, Duque DR, Murphy MSQ, Hawken S, Pham-Huy A, Kwong J, Deeks SL, Potter BK, Crowcroft NS, Bulman DE, Chakraborty P, Little J.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1378-1391. doi: 10.1080/21645515.2018.1433971. Epub 2018 Feb 26.

15.

Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease.

Tsang RSW, Ahmad T, Tyler S, Lefebvre B, Deeks SL, Gilca R, Hoang L, Tyrrell G, Van Caeseele P, Van Domselaar G, Jamieson FB.

Int J Infect Dis. 2018 Apr;69:55-62. doi: 10.1016/j.ijid.2018.01.019. Epub 2018 Feb 4.

16.

Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.

Guerra FM, Crowcroft NS, Friedman L, Deeks SL, Halperin SA, Severini A, Hatchette TF, Bolotin S; Immunity of Canadians and Risk of Epidemics (iCARE) Network.

Vaccine. 2018 Feb 28;36(10):1248-1255. doi: 10.1016/j.vaccine.2018.01.002. Epub 2018 Feb 2. Review.

PMID:
29398276
17.

Case-control study of household contacts to examine immunological protection from Bordetella pertussis transmission - study protocol.

Bolotin S, Johnson C, Quach S, Ambrose A, DeCoutere S, Deeks SL, Drews S, Faheem A, Green K, Halperin SA, Hoang L, Jamieson F, Kollmann T, Marchand-Austin A, McCormack D, McGeer A, Murti M, Bba AO, Rebbapragada A, Vanderkooi OG, Wang J, Warshawsky B, Crowcroft NS; Canadian Immunization Research Network Provincial Collaborative Network.

CMAJ Open. 2017 Dec 19;5(4):E872-E877. doi: 10.9778/cmajo.20170072.

18.

Human papillomavirus vaccines.

Ismail SJ, Deeks SL.

CMAJ. 2017 Sep 25;189(38):E1212. doi: 10.1503/cmaj.150465. Review. No abstract available.

19.

The basic reproduction number (R0) of measles: a systematic review.

Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, Crowcroft NS.

Lancet Infect Dis. 2017 Dec;17(12):e420-e428. doi: 10.1016/S1473-3099(17)30307-9. Epub 2017 Jul 27. Review.

PMID:
28757186
20.

Methods used for immunization coverage assessment in Canada, a Canadian Immunization Research Network (CIRN) study.

Wilson SE, Quach S, MacDonald SE, Naus M, Deeks SL, Crowcroft NS, Mahmud SM, Tran D, Kwong J, Tu K, Gilbert NL, Johnson C, Desai S.

Hum Vaccin Immunother. 2017 Aug 3;13(8):1928-1936. doi: 10.1080/21645515.2017.1319022. Epub 2017 Jul 14.

21.

Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015.

Thomas S, Hiebert J, Gubbay JB, Gournis E, Sharron J, Severini A, Jiaravuthisan M, Shane A, Jaeger V, Crowcroft NS, Fediurek J, Sander B, Mazzulli T, Schulz H, Deeks SL.

Emerg Infect Dis. 2017 Jul;23(7):1063-1069. doi: 10.3201/eid2307.161145.

22.

Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012-15.

Harris T, Nair J, Fediurek J, Deeks SL.

Vaccine. 2017 May 2;35(19):2600-2604. doi: 10.1016/j.vaccine.2017.03.035. Epub 2017 Mar 29.

23.

Immunization information systems in Canada: Attributes, functionality, strengths and challenges. A Canadian Immunization Research Network study.

Wilson SE, Quach S, MacDonald SE, Naus M, Deeks SL, Crowcroft NS, Mahmud SM, Tran D, Kwong JC, Tu K, Johnson C, Desai S.

Can J Public Health. 2017 Mar 1;107(6):e575-e582. doi: 10.17269/cjph.107.5679.

PMID:
28252378
24.

Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella pertussis.

Marchand-Austin A, Tsang RSW, Guthrie JL, Ma JH, Lim GH, Crowcroft NS, Deeks SL, Farrell DJ, Jamieson FB.

J Clin Microbiol. 2017 May;55(5):1446-1453. doi: 10.1128/JCM.02436-16. Epub 2017 Feb 22.

25.

Invasive serogroup W Neisseria meningitidis (MenW) in Ontario, Canada shows potential clonal replacement during the period January 1, 2009 to June 30, 2016.

Tsang RS, Deeks SL, Wong K, Marchand-Austin A, Jamieson FB.

Can Commun Dis Rep. 2016 Dec 1;42(12):263-266. eCollection 2016 Dec 1.

26.

Assessing the risk of intussusception and rotavirus vaccine safety in Canada.

Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, Crowcroft NS, Halperin SA, Desai S, Naus M, Sanford CJ, Mahmud SM, Deeks SL.

Hum Vaccin Immunother. 2017 Mar 4;13(3):703-710. doi: 10.1080/21645515.2016.1240846. Epub 2016 Nov 11.

27.

Effectiveness of pertussis vaccination and duration of immunity.

Schwartz KL, Kwong JC, Deeks SL, Campitelli MA, Jamieson FB, Marchand-Austin A, Stukel TA, Rosella L, Daneman N, Bolotin S, Drews SJ, Rilkoff H, Crowcroft NS.

CMAJ. 2016 Nov 1;188(16):E399-E406. doi: 10.1503/cmaj.160193. Epub 2016 Sep 26.

28.

Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015.

Harris T, Wong K, Nair J, Fediurek J, Deeks SL.

Can Commun Dis Rep. 2016 Sep 1;42(9):181-186. eCollection 2016 Sep 1.

29.

Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.

Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL.

Vaccine. 2016 Sep 7;34(39):4678-4683. doi: 10.1016/j.vaccine.2016.08.020. Epub 2016 Aug 12.

30.
31.

Can mobile technologies improve on-time vaccination? A study piloting maternal use of ImmunizeCA, a Pan-Canadian immunization app.

Atkinson KM, Westeinde J, Ducharme R, Wilson SE, Deeks SL, Crowcroft N, Hawken S, Wilson K.

Hum Vaccin Immunother. 2016 Oct 2;12(10):2654-2661. doi: 10.1080/21645515.2016.1194146. Epub 2016 Jun 20.

32.

Barriers and facilitators to the use of an immunization application: a qualitative study supplemented with Google Analytics data.

Burgess K, Atkinson KM, Westeinde J, Crowcroft N, Deeks SL, Wilson K; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group.

J Public Health (Oxf). 2017 Sep 1;39(3):e118-e126. doi: 10.1093/pubmed/fdw032.

33.

Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.

Wilson SE, Rosella LC, Wang J, Le Saux N, Crowcroft NS, Harris T, Bolotin S, Deeks SL.

PLoS One. 2016 May 11;11(5):e0154340. doi: 10.1371/journal.pone.0154340. eCollection 2016.

34.
35.

Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada.

Drolet M, Deeks SL, Kliewer E, Musto G, Lambert P, Brisson M.

Vaccine. 2016 Apr 7;34(16):1874-80. doi: 10.1016/j.vaccine.2016.02.069. Epub 2016 Mar 5.

PMID:
26954465
36.

An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination.

Wilson K, Atkinson KM, Westeinde J, Bell C, Marty K, Fergusson D, Deeks SL, Crowcroft N, Bettinger JA.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1738-48. doi: 10.1080/21645515.2016.1152434. Epub 2016 Feb 23.

37.

The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting - Can we do better?

Sander B, Wong WW, Yeung MW, Ormanidhi O, Atkin K, Murphy J, Krahn M, Deeks SL.

Vaccine. 2016 Apr 7;34(16):1936-44. doi: 10.1016/j.vaccine.2016.02.016. Epub 2016 Feb 15.

PMID:
26892739
38.

The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013.

Desai S, Jamieson FB, Patel SN, Seo CY, Dang V, Fediurek J, Navaranjan D, Deeks SL.

PLoS One. 2015 Nov 16;10(11):e0142179. doi: 10.1371/journal.pone.0142179. eCollection 2015.

39.

The Health Burden of Invasive Meningococcal Disease: A Systematic Review.

Strifler L, Morris SK, Dang V, Tu HA, Minhas RS, Jamieson FB, Deeks SL, Crowcroft NS, Sander B.

J Pediatric Infect Dis Soc. 2016 Dec;5(4):417-430. Epub 2015 Oct 15. Review.

PMID:
26501470
40.

Trends in medical and nonmedical immunization exemptions to measles-containing vaccine in Ontario: an annual cross-sectional assessment of students from school years 2002/03 to 2012/13.

Wilson SE, Seo CY, Lim GH, Fediurek J, Crowcroft NS, Deeks SL.

CMAJ Open. 2015 Jul 17;3(3):E317-23. doi: 10.9778/cmajo.20140088. eCollection 2015 Jul-Sep.

41.

A spot of bother: Why varicella vaccine programs matter.

Harris T, Seo CY, Shing E, Wong K, Fediurek J, Deeks SL.

Can Commun Dis Rep. 2015 Oct 1;41(10):241-249. eCollection 2015 Oct 1.

43.

Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.

Wormsbecker AE, Wong K, Jamieson FB, Crowcroft NS, Deeks SL.

Vaccine. 2015 Oct 13;33(42):5678-5683. doi: 10.1016/j.vaccine.2015.08.023. Epub 2015 Aug 20.

44.

Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007-2011.

Wilson SE, Khan K, Gilca V, Miniota J, Deeks SL, Lim G, Eckhardt R, Bolotin S, Crowcroft NS.

BMC Infect Dis. 2015 Aug 18;15:341. doi: 10.1186/s12879-015-1039-0.

45.

Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity.

Bolotin S, Deeks SL, Marchand-Austin A, Rilkoff H, Dang V, Walton R, Hashim A, Farrell D, Crowcroft NS.

PLoS One. 2015 Jul 17;10(7):e0133209. doi: 10.1371/journal.pone.0133209. eCollection 2015.

46.

Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study.

Wormsbecker AE, Wang J, Rosella LC, Kwong JC, Seo CY, Crowcroft NS, Deeks SL.

PLoS One. 2015 Jul 15;10(7):e0129483. doi: 10.1371/journal.pone.0129483. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0138397.

47.

Improving vaccine registries through mobile technologies: a vision for mobile enhanced Immunization information systems.

Wilson K, Atkinson KM, Deeks SL, Crowcroft NS.

J Am Med Inform Assoc. 2016 Jan;23(1):207-11. doi: 10.1093/jamia/ocv055. Epub 2015 Jun 15.

PMID:
26078414
48.

Validation of infant immunization billing codes in administrative data.

Schwartz KL, Tu K, Wing L, Campitelli MA, Crowcroft NS, Deeks SL, Wilson SE, Wilson K, Gemmill I, Kwong JC.

Hum Vaccin Immunother. 2015;11(7):1840-7. doi: 10.1080/21645515.2015.1043499.

49.

Understanding Public Perceptions of the HPV Vaccination Based on Online Comments to Canadian News Articles.

Feinberg Y, Pereira JA, Quach S, Kwong JC, Crowcroft NS, Wilson SE, Guay M, Lei Y, Deeks SL; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group.

PLoS One. 2015 Jun 8;10(6):e0129587. doi: 10.1371/journal.pone.0129587. eCollection 2015.

50.

Vaccination attitudes and mobile readiness: A survey of expectant and new mothers.

Atkinson KM, Ducharme R, Westeinde J, Wilson SE, Deeks SL, Pascali D, Wilson K.

Hum Vaccin Immunother. 2015;11(4):1039-45. doi: 10.1080/21645515.2015.1009807.

Supplemental Content

Loading ...
Support Center